These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 25864092
1. Movement disorders and brain iron overload in a new subtype of aceruloplasminemia. Melgari JM, Marano M, Quattrocchi CC, Piperno A, Arosio C, Frontali M, Nuovo S, Siotto M, Salomone G, Altavilla R, di Biase L, Scrascia F, Squitti R, Vernieri F. Parkinsonism Relat Disord; 2015 Jun; 21(6):658-60. PubMed ID: 25864092 [No Abstract] [Full Text] [Related]
2. Central nervous system involvement in a rare genetic iron overload disorder. Bethlehem C, van Harten B, Hoogendoorn M. Neth J Med; 2010 Oct; 68(10):316-8. PubMed ID: 21071777 [Abstract] [Full Text] [Related]
8. Extending the aceruloplasminemia phenotype: NBIA on imaging and acanthocytosis, yet only minor neurological findings. Kassubek R, Uttner I, Schönfeldt-Lecuona C, Kassubek J, Connemann BJ. J Neurol Sci; 2017 May 15; 376():151-152. PubMed ID: 28431603 [No Abstract] [Full Text] [Related]
9. [Aceruloplasminemia, a rare condition not to be overlooked]. Lobbes H, Reynaud Q, Mainbourg S, Lega JC, Durieu I, Durupt S. Rev Med Interne; 2020 Nov 15; 41(11):769-775. PubMed ID: 32682623 [Abstract] [Full Text] [Related]
10. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate. Kuhn J, Bewermeyer H, Miyajima H, Takahashi Y, Kuhn KF, Hoogenraad TU. Brain Dev; 2007 Aug 15; 29(7):450-3. PubMed ID: 17307325 [Abstract] [Full Text] [Related]
14. Clinical relevance of heterozygosis for aceruloplasminemia. Borges MD, de Albuquerque DM, Lanaro C, Costa FF, Fertrin KY. Am J Med Genet B Neuropsychiatr Genet; 2019 Jun 15; 180(4):266-271. PubMed ID: 30901137 [Abstract] [Full Text] [Related]
15. Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia. Kenawi M, Rouger E, Island ML, Leroyer P, Robin F, Rémy S, Tesson L, Anegon I, Nay K, Derbré F, Brissot P, Ropert M, Cavey T, Loréal O. FASEB J; 2019 Dec 15; 33(12):13492-13502. PubMed ID: 31560858 [Abstract] [Full Text] [Related]
16. Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation. Suzuki Y, Yoshida K, Aburakawa Y, Kuroda K, Kimura T, Terada T, Kono S, Miyajima H, Yahara O. Intern Med; 2013 Dec 15; 52(13):1527-30. PubMed ID: 23812204 [Abstract] [Full Text] [Related]